Noxopharm will make an oral presentation at ESMO ASIA on 18 November, in which it will provide an update on the trial in Georgia. See: https://cslide.ctimeetingtech.com/asia2017/attendee/confcal/session/calendar?q=kelly
The award of Late Breaking Abstract by ESMO, together with a speaking spot, suggests NOX will present efficacy data from the combination of chemotherapy and NOX66. Under LBA rules, details of the abstract will not be released by ESMO before the actual presentation.
- Forums
- ASX - By Stock
- NOX
- ESMO - Oral presentation
NOX
noxopharm limited
Add to My Watchlist
0.00%
!
8.9¢

ESMO - Oral presentation
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.00M |
Open | High | Low | Value | Volume |
8.9¢ | 8.9¢ | 8.9¢ | $1.385K | 15.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 52934 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 10239 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 52934 | 0.088 |
2 | 83000 | 0.087 |
1 | 11764 | 0.085 |
1 | 6250 | 0.082 |
1 | 12345 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 10239 | 1 |
0.094 | 57000 | 1 |
0.095 | 7855 | 1 |
0.099 | 90000 | 1 |
0.100 | 57999 | 3 |
Last trade - 10.17am 17/09/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |